Deepak Chopra MD and Pondera Pharmaceuticals announce partnership.

 Deepak Chopra Endorphinate® is scientifically formulated to relieve emotional distress, including anxiety, cravings, anger and fatigue, when taken daily. Three additional products will be available soon: Deepak Chopra Endorphinate® PR, for enhanced pain relief, Deepak Chopra Endorphinate® ME for enhanced mood, and Deepak Chopra Endorphinate® PM, to enhance restful sleep.

Dr. Chopra was instrumental in the development of Endorphinate and, after experiencing its daily benefits, was inspired to formally partner with Pondera Pharmaceuticals. "I am pleased to partner with Pondera Pharmaceuticals to launch Deepak Chopra Endorphinate," said Dr. Chopra. "As I have been experiencing the beneficial effects of Endorphinate, I unhesitatingly endorse and support its use to help increase resistance to stress, anxiety, trauma, cravings, pain and fatigue." Since 1976, the founders and advisors of Pondera Pharmaceuticals have been researching ways to unleash the power of endorphins, the body's natural pain and stress relievers" according to Dr. Steven Crain, Executive Vice President and Chief Scientific Officer of Pondera’s Nutraceutical Division. "Those decades of research produced Endorphinate, and we are excited to work with Dr. Chopra to share its remarkable benefits with the public," said William Crain, Pondera President and CEO.

Pondera Pharmaceuticals
Founded in 2009 by Drs. Michael and Steven Crain and William E. Crain, Esq, Pondera Pharmaceuticals’ mission is to help people from all walks of life engage in and enjoy their personal and working lives with reduced distress and pain as well as increased pleasure and satisfaction. Other members of the Pondera team include Eric Simon, PhD, Professor, NYU Langone Medical Center, who identified opioid receptors in the brain and coined the term "endorphins"; Stanley M. Crain, PhD, Professor Emeritus, Albert Einstein College of Medicine, who discovered the bimodal nature of opioid receptors; Dr. Rudolph Tanzi, Professor, Harvard Medical School; Elliot J. Crane, MD, Professor, Stanford University School of Medicine and Lynn R. Webster, MD, FACPM, FASM, Medical Director and Founder, Lifetree Clinical Research® & Pain Clinic and Director-At-Large for the American Academy of Pain Medicine.
Additional product and company information can be found at ponderapharma.com.
.

Deepak Chopra, MD
Dr. Chopra is a global leader and pioneer in the field of mind-body medicine. He is a prolific author of more than sixty-four books, including nineteen New York Times bestsellers. He is a columnist for the San Francisco Chronicle and Washington Post on Faith and contributes regularly to Intent.com, CNN.com, and the Huffington Post. In addition, he hosts the popular Deepak Chopra Radio show on BlogTalk Radio. He is a popular international presenter and keynote speaker. Dr. Chopra is a fellow of the American College of Physicians, a member of the American Association of Clinical Endocrinologists, an adjunct professor of executive programs at Kellogg School of Management at Northwestern University, a distinguished scholar at Columbia University, and a senior scientist with the Gallup Organization. Before establishing the Chopra Center, Dr. Chopra served as chief of staff at Boston Regional Medical Center.

For more information, please contact William Crain: william@ponderapharma.com; (207) 688-4494